Recent News

• 03.25.2026 - HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
• 03.24.2026 - HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
• 02.10.2026 - ECG market keeps evolving thanks to AI, home monitoring and Epic integration
• 02.05.2026 - University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
• 12.15.2025 - HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
• 12.15.2025 - HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Recent Filings

• 03.19.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.17.2026 - DEF 14A Other definitive proxy statements
• 03.16.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 03.16.2026 - 8-K Current report
• 03.16.2026 - EX-99.1 EX-99.1
• 03.06.2026 - PRE 14A Other preliminary proxy statements
• 01.16.2026 - 8-K Current report
• 01.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.22.2025 - 4 Statement of changes in beneficial ownership of securities